Global Breast Biopsy Market to grow at a CAGR of 10.70% during the period 2017-2021

A breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer.

the worldwide breast biopsy market is projected to accrue lucrative gains by 2021. Breast biopsy tests are performed in order to detect and diagnose breast cancer as well as other diseases affecting the breast. Risk of breast cancer may increase with aging and can be observed in women over 40 years of age. Therefore, breast biopsy is a preferred choice for identifying complex tumors and diagnosing breast cancer.

Download free pdf request sample @

Major factors such as increasing prevalence of breast cancer among women and growing awareness about breast cancer screening programs can impel the market. Technological progressions in breast imaging equipment and advancement of minimally invasive methods can have a positive impact on the market during the forecast period (2017 to 2021).

Use of digital imaging has increased as it delivers more accurate images of the breast. The 3D digital mammogram captures a digital image of the breast and aids in the detection of smaller tumors, which are difficult to find using 2D mammography.  

For instance, Hologic Inc. recently developed the Brevera breast biopsy system with CorLumina imaging technology, which is a real-time breast biopsy as well as verification system. This system is designed for 2D and 3D biopsy and for improving the accuracy of diagnosis. Its real-time imaging can provide information at the point of care, which can be beneficial to make informed decisions. This system also improves patient care and streamlines the overall biopsy process from start to end.     

On the down side, lack of awareness about availability of advanced breast biopsy techniques and risk of infection resulting from these procedures and uncertain regulatory approval procedures for medical devices can hamper the growth of the market. Infections are caused due to inappropriate care of breast biopsy cuts and wounds. Additionally, substandard healthcare facilities, particularly in developing countries, can restrain market growth.  

The worldwide breast biopsy market can be fragmented on the basis of product type, end-user, and modality. Based on type, the breast biopsy market can be segmented into breast biopsy imaging guidance systems, biopsy needles, biopsy needle-based systems, and others. As per end user, the market can be divided into hospitals, ASCs, research centers, and others.  

Browse full report with table of control @

Geographically, the breast biopsy market can be divided into the Americas, Europe, Middle East, and Africa (EMEA), and Asia Pacific (APAC). The Americas represent one of the largest markets owing to developed healthcare infrastructure and availability of advanced breast biopsy techniques. Rising incidence of breast cancer and increased reimbursement rates in the U.S. for image-guided biopsies can also drive demand in this region.      

Prominent players operating in the breast biopsy market include Leica Biosystems, C.R. Bard, Hologic, and BD. The market is highly competitive and companies are largely focusing on strengthening their presence in developing countries by expanding their businesses. Also, companies are competing by offering different products at varied prices.

Visit, Trending reports here:-

Global Test preparation market in US to grow at a CAGR of 5.51% during the period 2017-2021 –

Global Smart Card IC Market 2017-2021 –

Global Music Production Software Market 2017-2021 –

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: California
Country: United States